)
Stefanos Theoharis
Chief Executive Officer,
OneChain Therapeutics
Sessions
-
03-Sep-2025Theatre 1Panel: Emerging tech in CGT – What's next?
-
03-Sep-2025Theatre 1Spain’s biotech leap: Manufacturing, clinical capacity & EU integration
-
04-Sep-2025Theatre 1Spotlight: Development of autologous and iPSC-derived allogeneic products for leukaemia and solid cancer.